Evidence map›Paper›PMID 34452693›Full record

ArticleAdvances in pharmacology (San Diego, Calif.)2021

Inappropriately sweet: Environmental endocrine-disrupting chemicals and the diabetes pandemic.

Margaret C Schulz, Robert M Sargis

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Advances in pharmacology (San Diego, Calif.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07142447 (Understanding and Preventing the Impact of Endocrine Disruptors on the Hypothalamus-pituitary Axis in Sensitive Populations. Hypiend- Perinatal Study.), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07142447 narecruitingnot on this mapstarted 2025, after this paper: background citation

Understanding and Preventing the Impact of Endocrine Disruptors on the Hypothalamus-pituitary Axis in Sensitive Populations. Hypiend- Perinatal Study.

TypeinterventionalSponsorFundació Institut Germans Trias i PujolRan2025 to 2027Enrolled810ConditionsPregnancy, ChildrenArmsMulti-Component Behavioral intervention, Control group
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Obesogens: a unifying theory for the global rise in obesity.International journal of obesity (2005) · 2024
    Review
  11. Article
  12. Hormonal Injustice: Environmental Toxicants as Drivers of Endocrine Health Disparities.Endocrinology and metabolism clinics of North America · 2023
    Review
  13. Article
  14. Critical Overview on Endocrine Disruptors in Diabetes Mellitus.International journal of molecular sciences · 2023
    Review
  15. Stress and human health in diabetes: A report from the 19Journal of clinical and translational science · 2023
    Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Margaret C SchulzSchool of Public Health, University of Illinois at Chicago, Chicago, IL, United States; Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Illinois at Chicago, Chicago, IL, United States.
Robert M SargisSchool of Public Health, University of Illinois at Chicago, Chicago, IL, United States; Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Illinois at Chicago, Chicago, IL, United States; Jesse Brown Veterans Affairs Medical Center, Chicago, IL, United States. Electronic address: rsargis@uic.edu.
University of Illinois Chicago · US

Funding

Pilot Program CoreP30ES027792 · NIEHS · UNIVERSITY OF CHICAGO · PI Gokhan M. Mutlu, Gail S Prins · 2017 to 2026
$13.6M
Medical Scientist Training ProgramT32GM079086 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ROSENBLATT, MARK I · 2007 to 2023
$6.9M
Selenoproteins in Arsenic-Induced Metabolic DysfunctionR01ES028879 · NIEHS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SARGIS, ROBERT M · 2018 to 2022
$2.7M
Protection against Arsenic-Induced Neurologic Defects by Brain DHA EnrichmentR21ES030884 · NIEHS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SARGIS, ROBERT M · 2019 to 2020
$440k
NIEHS NIH HHS P30 ES027792NIEHS NIH HHS R01 ES028879NIEHS NIH HHS R21 ES030884NIGMS NIH HHS T32 GM079086
6 · The paper itself

Abstract

Afflicting hundreds of millions of individuals globally, diabetes mellitus is a chronic disorder of energy metabolism characterized by hyperglycemia and other metabolic derangements that result in significant individual morbidity and mortality as well as substantial healthcare costs. Importantly, the impact of diabetes in the United States is not uniform across the population; rather, communities of color and those with low income are disproportionately affected. While excessive caloric intake, physical inactivity, and genetic susceptibility are undoubted contributors to diabetes risk, these factors alone fail to fully explain the rapid global rise in diabetes rates. Recently, environmental contaminants acting as endocrine-disrupting chemicals (EDCs) have been implicated in the pathogenesis of diabetes. Indeed, burgeoning data from cell-based, animal, population, and even clinical studies now indicate that a variety of structurally distinct EDCs of both natural and synthetic origin have the capacity to alter insulin secretion and action as well as global glucose homeostasis. This chapter reviews the evidence linking EDCs to diabetes risk across this spectrum of evidence. It is hoped that improving our understanding of the environmental drivers of diabetes development will illuminate novel individual-level and policy interventions to mitigate the impact of this devastating condition on vulnerable communities and the population at large.

Indexed as

Diabetes MellitusEndocrine DisruptorsAnimalsEnergy MetabolismHumansPandemicsEndocrine DisruptorsBisphenolDiabetesEndocrine-disrupting chemicalEndocrine disruptorGlucoseInsulinPesticidePhthalatePollutionPolychlorinated biphenyl

Identifiers

PMID34452693
PMCPMC8714029
OpenAlexW3195381056

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.